Indications
Raltrox Injection is used to relieve moderate to severe pain, including pain associated with myocardial infarction (MI). It can also be given alongside balanced anesthesia, for pain control before and after surgery, and for pain relief during labor and delivery.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Nalbuphine Hydrochloride is a potent synthetic analgesic, with pain-relieving strength essentially equal to that of morphine on a milligram-for-milligram basis. Receptor studies show that it binds to mu, kappa, and delta receptors, but not to sigma receptors, acting primarily as a kappa agonist with partial mu-antagonist activity. Given intravenously, it starts working within 2 to 3 minutes; given subcutaneously or intramuscularly, it takes effect in under 15 minutes. Its plasma half-life is about 5 hours, and clinical studies have found its pain-relieving effect to last anywhere from 3 to 6 hours.
Pregnancy & Breastfeeding
Pregnancy category B. Nalbuphine crosses the placenta readily and quickly, and there are no well-controlled studies in pregnant women, so it should be used in pregnancy only when clearly needed. Limited data show that small amounts pass into breast milk (under 1% of the maternal dose), with no expected clinical effect on the infant; even so, caution is advised when giving Nalbuphine to a breastfeeding woman.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.